Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071890
Status:
COMPLETED
Last Update Posted:
2010-10-05
First Post:
2003-11-03
Brief Title:
Phase IIIII Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cellsmm3 Who Received Antiretroviral Tx
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
040018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Irini Sereti MDNational Institute of Allergy and Infectious Diseases
Old Organization:
National Institutes of Health
Collaborators
| Name | Class |
|---|---|
| ANRS Emerging Infectious Diseases | OTHER_GOV |